Drug Database
Ref. Compounds
Structure Search
Hot Search： Flibanserin | Cariprazine | Rolapitant | Xuriden | Rolapitant Hydrochloride Hydrate

Home> Industry News >R&D >Main Body

  • Industry News

Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme's Lemtrada® (alemtuzumab) in Clinical Trials

2015-10-09 00:00
R&D
Pharmacodia.com
Read：339 Favorite  0
  Share
相关阅读
You may interest

Copyright©2020 药渡经纬信息科技（北京）有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |（京）-经营性-2015-0023（互联网药品信息服务资格证书）

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码